Protein Kinase C Peptide Substrate ol isoflavone DCC-2701 effectively reduces tumor burden

DCC-2701 effectively reduces tumor burden in vivo and blocks c-MET pTyr(1349)-mediated signaling

AG-13958 (AG-013958)

37 µg/mL following incubation of the parasite strains with Acoziborole for 72 h

a biomarker of CDK8 inhibition

Protein Kinase C Peptide Substrate ol isoflavone DCC-2701 effectively reduces tumor burdenProtein Kinase C Peptide Substrate is targeted to a specific cellular compartment in a manner dependent on second messengers and on specific adapter proteins in response to extracellular signals that activate G protein coupled receptors, tyrosine kinase receptors, or tyrosine kinase coupled receptors. Protein Kinase C Peptide Substrate then regulates various physiological functions including the activation of nervous, endocrine, exocrine,